IMV Inc. IMV.TO Stock
IMV Inc. Price Chart
IMV Inc. IMV.TO Financial and Trading Overview
| IMV Inc. stock price | 1.12 CAD |
| Previous Close | 1.12 CAD |
| Open | 1.13 CAD |
| Bid | 0.7 CAD x 0 |
| Ask | 0.7 CAD x 0 |
| Day's Range | 1.07 - 1.13 CAD |
| 52 Week Range | 0.62 - 13.1 CAD |
| Volume | 15.76K CAD |
| Avg. Volume | 12.15K CAD |
| Market Cap | 13.12M CAD |
| Beta (5Y Monthly) | 1.522358 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 CAD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 37.4 CAD |
IMV.TO Valuation Measures
| Enterprise Value | 20.79M CAD |
| Trailing P/E | N/A |
| Forward P/E | -0.36129034 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 39.869278 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 63.195 |
| Enterprise Value/EBITDA | -0.525 |
Trading Information
IMV Inc. Stock Price History
| Beta (5Y Monthly) | 1.522358 |
| 52-Week Change | -88.21% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 13.1 CAD |
| 52 Week Low | 0.62 CAD |
| 50-Day Moving Average | 1.05 CAD |
| 200-Day Moving Average | 3.09 CAD |
IMV.TO Share Statistics
| Avg. Volume (3 month) | 12.15K CAD |
| Avg. Daily Volume (10-Days) | 0 CAD |
| Shares Outstanding | 11.71M |
| Float | 11.05M |
| Short Ratio | N/A |
| % Held by Insiders | 0.41% |
| % Held by Institutions | 20.36% |
| Shares Short | 16.41K |
| Short % of Float | 0.13% |
| Short % of Shares Outstanding | 0.13% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -12239.20% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -61.78% |
| Return on Equity (ttm) | -508.58% |
Income Statement
| Revenue (ttm) | 329K CAD |
| Revenue Per Share (ttm) | 0.04 CAD |
| Quarterly Revenue Growth (yoy) | 75.00% |
| Gross Profit (ttm) | -23281000 CAD |
| EBITDA | -39584000 CAD |
| Net Income Avi to Common (ttm) | -37991000 CAD |
| Diluted EPS (ttm) | -6.11 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 21.22M CAD |
| Total Cash Per Share (mrq) | 1.81 CAD |
| Total Debt (mrq) | 28.9M CAD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 2.929 |
| Book Value Per Share (mrq) | -0.691 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -33396000 CAD |
| Levered Free Cash Flow (ttm) | -21513876 CAD |
Profile of IMV Inc.
| Country | Canada |
| State | NS |
| City | Dartmouth |
| Address | 130 Eileen Stubbs Avenue |
| ZIP | B3B 2C4 |
| Phone | 902 492 1819 |
| Website | https://www.imv-inc.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 63 |
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and MSI-H solid tumors, as well as in Phase I clinical trial for breast cancer. It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.
Q&A For IMV Inc. Stock
What is a current IMV.TO stock price?
IMV Inc. IMV.TO stock price today per share is 1.12 CAD.
How to purchase IMV Inc. stock?
You can buy IMV.TO shares on the Toronto exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for IMV Inc.?
The stock symbol or ticker of IMV Inc. is IMV.TO.
Which industry does the IMV Inc. company belong to?
The IMV Inc. industry is Biotechnology.
How many shares does IMV Inc. have in circulation?
The max supply of IMV Inc. shares is 11.71M.
What is IMV Inc. Price to Earnings Ratio (PE Ratio)?
IMV Inc. PE Ratio is 0.00000000 now.
What was IMV Inc. earnings per share over the trailing 12 months (TTM)?
IMV Inc. EPS is 0 CAD over the trailing 12 months.
Which sector does the IMV Inc. company belong to?
The IMV Inc. sector is Healthcare.